Myeloma BCMA Therapy In Spotlight: EMA Considers Fast Tracking GSK Filing

EU Filing Understood To Be Expected in H1 2020

 
• By Neena Brizmohun
Running
GSK is leading the race to market a BCMA-targeting therapy for myeloma • Source: Shutterstock

More from Product Reviews

More from Pink Sheet